Olfr463 Inhibitors
Olfr463, a pivotal member of the olfactory receptor family, plays a central role in the intricate process of odorant signal transduction within the nose. As a G-protein-coupled receptor (GPCR) with a 7-transmembrane domain structure, Olfr463 is characterized by its unique single coding-exon gene. This receptor is intricately involved in initiating a neuronal response upon interacting with odorant molecules, ultimately leading to the perception of specific smells. The vast olfactory receptor gene family, independent in nomenclature, underscores the complexity and significance of these proteins in orchestrating the diverse range of olfactory experiences.
The inhibition of Olfr463 involves a multifaceted interplay of mechanisms targeting various cellular pathways. Disruption of the cAMP signaling pathway through phosphodiesterase inhibition, enhanced cAMP production via adenylyl cyclase activation, and interference with the MAPK pathway via specific inhibitors are among the strategies employed to indirectly inhibit Olfr463. Ion channel blockers and G protein inhibitors disrupt ionotropic processes and G protein function, respectively, impairing the receptor's ability to initiate neuronal responses. Modulation of calcium and PKC signaling pathways further influences the transduction process of Olfr463, highlighting the intricate web of cellular events crucial for olfactory receptor function. Additional interventions, such as targeting cyclic nucleotide-gated channels, microtubule dynamics, Raf-MEK-ERK pathways, and calcium-calmodulin-dependent kinase II (CaMKII), contribute to the comprehensive inhibition of Olfr463 by affecting diverse cellular processes involved in olfactory signal transduction. In summary, Olfr463 stands as a key player in the complex network of olfactory receptors, orchestrating the initial steps in the perception of smells. Its inhibition involves a sophisticated array of interventions, each strategically targeting specific cellular pathways crucial for olfactory signal transduction. This intricate interplay showcases the depth of understanding required to unravel the complexities of olfactory receptor function and the potential for manipulating these processes for scientific exploration.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram, a phosphodiesterase 4 (PDE4) inhibitor, modulates the cAMP signaling pathway. By inhibiting PDE4 activity, it increases intracellular cAMP levels, negatively affecting the olfactory transduction process. This disruption hampers the G protein-mediated transduction of odorant signals by Olfr463. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126, a mitogen-activated protein kinase (MAPK) inhibitor targeting the ERK pathway, disrupts the downstream signaling events of Olfr463. This compound influences neuronal responses to odorant molecules by specifically targeting the MAPK pathway, indirectly inhibiting the G protein-coupled receptor function of Olfr463. | ||||||
Amiloride | 2609-46-3 | sc-337527 | 1 g | $296.00 | 7 | |
Amiloride, an ion channel blocker, interferes with the normal ion flux associated with olfactory signal transduction. By disrupting the ionotropic processes, this chemical indirectly inhibits Olfr463, impairing its ability to initiate a neuronal response to odorant molecules. | ||||||
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $451.00 | 3 | |
Pertussis Toxin, a G protein inhibitor, specifically targets the Gα subunit involved in olfactory signal transduction. This compound disrupts the G protein-mediated transduction process, leading to the indirect inhibition of Olfr463. The interference occurs at the molecular level, impacting the receptor's ability to recognize odorant signals. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Verapamil, a calcium channel antagonist, interferes with intracellular calcium levels. By disrupting calcium-mediated signaling events, this chemical indirectly inhibits Olfr463, as calcium plays a crucial role in the modulation of olfactory receptor proteins. The disruption affects the receptor's ability to transduce odorant signals effectively. | ||||||
Bryostatin 1 | 83314-01-6 | sc-201407 | 10 µg | $245.00 | 9 | |
Bryostatin 1, a protein kinase C (PKC) activator, modulates the PKC signaling pathway. This chemical indirectly inhibits Olfr463 by influencing downstream PKC-mediated events, disrupting the normal transduction of odorant signals. The altered phosphorylation events impair the receptor's ability to initiate a neuronal response to odorants. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Taxol, a microtubule-stabilizing agent, disrupts microtubule dynamics involved in intracellular transport. By affecting cellular processes related to olfactory signal transduction, this chemical indirectly inhibits Olfr463, influencing the receptor's ability to initiate a neuronal response to odorant molecules. | ||||||
GW 5074 | 220904-83-6 | sc-200639 sc-200639A | 5 mg 25 mg | $106.00 $417.00 | 10 | |
GW5074, a Raf-1 kinase inhibitor, targets the Raf-MEK-ERK pathway. This compound disrupts downstream signaling events associated with Olfr463, indirectly inhibiting the G protein-coupled receptor function. The interference occurs at the level of Raf-1 kinase, impacting the transduction of odorant signals. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
KN-93, a CaMKII inhibitor, modulates CaMKII-dependent processes in olfactory signal transduction. This chemical indirectly inhibits Olfr463 by interfering with calcium-calmodulin-dependent kinase II (CaMKII), disrupting downstream events crucial for G protein-mediated transduction of odorant signals. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
BAPTA-AM, a calcium chelator, reduces intracellular calcium levels. By chelating calcium ions, this chemical indirectly inhibits Olfr463, as calcium is integral to the modulation of olfactory receptor proteins. The disruption affects the receptor's ability to transduce odorant signals effectively. | ||||||